Literature DB >> 25916813

Associations with smoking and shared epitope differ between IgA- and IgG-class antibodies to cyclic citrullinated peptides in early rheumatoid arthritis.

Anna Svärd1, Thomas Skogh2, Lars Alfredsson3, Anna Ilar4, Lars Klareskog5, Camilla Bengtsson4, Alf Kastbom2.   

Abstract

OBJECTIVE: Smoking and HLA-DRB1/shared epitope (SE) alleles are risk factors for rheumatoid arthritis (RA) characterized by seropositivity for antibodies targeting citrullinated proteins (ACPAs)/cyclic citrullinated peptides (anti-CCP). Previously, mainly IgG-class antibodies have been studied. IgA-class antibodies are to a great extent related to mucosal immunity. The aim of this study was to explore interrelations between cigarette smoking, presence of SE, and seropositivity for circulating IgA and/or IgG anti-CCP antibodies among patients with early RA, to determine whether ACPAs of the IgA subclass are regulated by different mechanisms than those of the IgG subclass.
METHODS: Two cohorts of patients with early RA, from the first Epidemiological Investigations of RA trial (n = 1,663) and the second Early Intervention in RA trial (n = 199), were grouped into 4 subsets based on anti-CCP subclass status (IgG-/IgA-, IgG-/IgA+, IgG+/IgA-, and IgG+/IgA+), and each subset was compared with regard to associations with smoking (current and former) and presence of SE. Interaction between smoking and SE was calculated using the attributable proportion (AP) due to interaction (assessing deviation from additivity of effects).
RESULTS: Smoking was overrepresented among IgA anti-CCP-positive RA patients, regardless of whether IgG anti-CCP were present, whereas in patients with IgG anti-CCP alone, no association with smoking was found. SE alleles were overrepresented among IgG anti-CCP-positive patients, regardless of IgA anti-CCP status, and was not seen in patients with IgA anti-CCP alone. An interaction between ever smoking and SE was found with regard to the risk of IgG+/IgA+ RA (AP 0.5, 95% confidence interval 0.4, 0.6). No significant interaction was observed with regard to the risk of IgG-/IgA+ RA or IgG+/IgA- RA.
CONCLUSION: In patients with RA, a history of ever smoking was associated with seropositivity for IgA anti-CCP antibodies, whereas presence of SE was associated with seropositivity for IgG anti-CCP antibodies. An interaction between ever smoking and the SE was limited to the RA subset characterized by seropositivity for both IgG and IgA anti-CCP. These findings provide novel evidence that anti-CCP-positive RA can be divided into at least 3 serologically distinct subsets associated with different risk factors, indicating different modes of pathogenesis in RA.
© 2015, American College of Rheumatology.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25916813     DOI: 10.1002/art.39170

Source DB:  PubMed          Journal:  Arthritis Rheumatol        ISSN: 2326-5191            Impact factor:   10.995


  24 in total

1.  Changes in anti-citrullinated protein antibody isotype levels in relation to disease activity and response to treatment in early rheumatoid arthritis.

Authors:  A Kastbom; K Roos Ljungberg; M Ziegelasch; J Wetterö; T Skogh; K Martinsson
Journal:  Clin Exp Immunol       Date:  2018-10-14       Impact factor: 4.330

2.  Immunoglobulin (Ig)G1 and IgG4 anti-cyclic citrullinated peptide (CCP) associate with shared epitope, whereas IgG2 anti-CCP associates with smoking in patients with recent-onset rheumatoid arthritis (the Swedish TIRA project).

Authors:  K Martinsson; A Johansson; A Kastbom; T Skogh
Journal:  Clin Exp Immunol       Date:  2017-01-10       Impact factor: 4.330

Review 3.  Reinterpreting Evidence of Rheumatoid Arthritis-Associated Interstitial Lung Disease to Understand Etiology.

Authors:  Emily K Wu; Robert D Ambrosini; R Matthew Kottmann; Christopher T Ritchlin; Edward M Schwarz; Homaira Rahimi
Journal:  Curr Rheumatol Rev       Date:  2019

4.  Anticyclic Citrullinated Peptide Antibodies 3.1 and Anti-CCP-IgA Are Associated with Increasing Age in Individuals Without Rheumatoid Arthritis.

Authors:  Heather M Berens; Kristen J Polinski; Ted R Mikuls; Sonia Khatter; Justin August; Ashley Visser; Michael Mahler; Michael H Weisman; James R O'Dell; Richard M Keating; Jane H Buckner; Peter K Gregersen; Jill M Norris; V Michael Holers; Kevin D Deane; M Kristen Demoruelle
Journal:  J Rheumatol       Date:  2019-04-15       Impact factor: 4.666

Review 5.  Anti-phospholipid Antibodies and Smoking: An Overview.

Authors:  Steven R Binder; Christine M Litwin
Journal:  Clin Rev Allergy Immunol       Date:  2017-08       Impact factor: 8.667

6.  Anti-citrullinated protein antibodies cause arthritis by cross-reactivity to joint cartilage.

Authors:  Changrong Ge; Dongmei Tong; Bibo Liang; Erik Lönnblom; Nadine Schneider; Cecilia Hagert; Johan Viljanen; Burcu Ayoglu; Roma Stawikowska; Peter Nilsson; Gregg B Fields; Thomas Skogh; Alf Kastbom; Jan Kihlberg; Harald Burkhardt; Doreen Dobritzsch; Rikard Holmdahl
Journal:  JCI Insight       Date:  2017-07-06

Review 7.  The immunopathogenesis of seropositive rheumatoid arthritis: from triggering to targeting.

Authors:  Vivianne Malmström; Anca I Catrina; Lars Klareskog
Journal:  Nat Rev Immunol       Date:  2016-12-05       Impact factor: 53.106

Review 8.  Autoantibodies in Rheumatoid Arthritis - Laboratory and Clinical Perspectives.

Authors:  Johan Rönnelid; Carl Turesson; Alf Kastbom
Journal:  Front Immunol       Date:  2021-05-14       Impact factor: 7.561

Review 9.  Determining in which pre-arthritis stage HLA-shared epitope alleles and smoking exert their effect on the development of rheumatoid arthritis.

Authors:  Fenne Wouters; Marc P Maurits; Laurette van Boheemen; Marloes Verstappen; Kulveer Mankia; Xanthe M E Matthijssen; Annemarie L Dorjée; Paul Emery; Rachel Knevel; Dirkjan van Schaardenburg; René E M Toes; Annette H M van der Helm-van Mil
Journal:  Ann Rheum Dis       Date:  2021-07-20       Impact factor: 19.103

10.  A Comprehensive Evaluation of the Relationship Between Different IgG and IgA Anti-Modified Protein Autoantibodies in Rheumatoid Arthritis.

Authors:  Caroline Grönwall; Lisa Liljefors; Holger Bang; Aase H Hensvold; Monika Hansson; Linda Mathsson-Alm; Lena Israelsson; Vijay Joshua; Anna Svärd; Ragnhild Stålesen; Philip J Titcombe; Johanna Steen; Luca Piccoli; Natalia Sherina; Cyril Clavel; Elisabet Svenungsson; Iva Gunnarsson; Saedis Saevarsdottir; Alf Kastbom; Guy Serre; Lars Alfredsson; Vivianne Malmström; Johan Rönnelid; Anca I Catrina; Karin Lundberg; Lars Klareskog
Journal:  Front Immunol       Date:  2021-05-20       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.